Millennium Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-157,000
Closed -$1.05M 6719
2023
Q3
$1.05M Buy
+157,000
New +$1.3M ﹤0.01% 4156

Other funds holding PNT

Millennium Management's PNT Position: Q4 2023 in Review

Millennium Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 851,735 shares — an estimated $5.68M sold.

Millennium Management first reported a position in PNT in Q4 2021 and held it in 6 quarters. The position peaked at $5.68M in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Millennium Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Millennium Management sold 851,735 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $5.68M.
  • Millennium Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Millennium Management's POINT Biopharma Global Inc. Common Stock position peaked at $5.68M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.